List of Drug Master Files (KDMF) for Benzenemethanol, alpha-(1-(methylamino)ethyl)-, hydrochloride, (S-(R,R))- (9CI) Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Korea.

Question

Benzenemethanol, alpha-(1-(methylamino)ethyl)-, hydrochloride, (S-(R,R))- (9CI) Manufacturers | Traders | Suppliers

score 12 · Accepted Answer

We have 2 companies offering Benzenemethanol, alpha-(1-(methylamino)ethyl)-, hydrochloride, (S-(R*,R*))- (9CI)

Get in contact with the supplier of your choice:

List of Drug Master Files (KDMF) for Benzenemethanol, alpha-(1-(methylamino)ethyl)-, hydrochloride, (S-(R*,R*))- (9CI) Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Korea.

Benzenemethanol, alpha-(1-(methylamino)ethyl)-, hydrochloride, (S-(R*,R*))- (9CI)

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

37 API Suppliers

24 USDMF

10 CEP/COS

1 JDMF

3 EU WC

6 KDMF

12 NDC API

12 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

PRICE INFORMATION

API Reference Price

API Exports

API Imports

FDF Imports

FINISHED DOSAGE FORMULATIONS

312 FDF Dossiers

112 FDA Orange Book

3 Europe

114 Canada

50 South Africa

33 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 200MG;30MG

CAPSULE;ORAL - 8MG;60MG

TABLET, EXTENDED RELEASE;ORAL - 240MG

TABLET, EXTENDED RELEASE;ORAL - 60MG;120MG

CAPSULE;ORAL - EQ 200MG FREE ACID AND POTASSIUM SALT;30MG

TABLET;ORAL - 2MG;200MG;30MG

TABLET, EXTENDED RELEASE;ORAL - 1.2GM;120MG

TABLET, EXTENDED RELEASE;ORAL - 600MG;60MG

TABLET, EXTENDED RELEASE;ORAL - 180MG;240MG

SOLUTION;ORAL - 200MG/5ML;2.5MG/5ML;30MG/5ML

SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SOLUTION;ORAL - 5MG/5ML;60MG/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

SYRUP;ORAL - 2MG/5ML;10MG/5ML;30MG/5ML

RELATED EXCIPIENT COMPANIES

1 Minakem

9 Rochem International Inc

21 SPI Pharma

2 Seqens

13 DKSH

3 Jai Radhe Sales

2 Pharm-RX Chemical

12 Boai NKY Pharmaceuticals Ltd

1 Chynops Pharma

16 Gangwal Healthcare

13 Nanjing Well Pharmaceutical

2 Pfanstiehl

4 ACG Worldwide

15 Actylis

4 Aeon Procare

3 Alcedo Pharmachem

12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

38 BASF

1 Bioplus Life Sciences

2 Clariant

12 Corel Pharma Chem

7 DFE Pharma

2 Finar

14 Gangwal Chemicals

1 Huzhou Sunflower Pharmaceutical

7 Ideal Cures Pvt Ltd

5 Ingredion Pharma Solutions

39 Kerry

4 Kima Chemical

6 Lonza Capsugel

2 Lubrizol Life Science Health

18 Microlex e.U

2 Nanjing Bold Chemical

1 NEWEDGE Overseas

2 Nomisma Healthcare

List of Drug Master Files (KDMF) for Benzenemethanol, alpha-(1-(methylamino)ethyl)-, hydrochloride, (S-(R,R))- (9CI) Active Pharmaceutical Ingredient (API) submitted to the Review Authority in Korea.

Benzenemethanol, alpha-(1-(methylamino)ethyl)-, hydrochloride, (S-(R,R))- (9CI)

SOLUTION;ORAL - 4MG/5ML;5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

SOLUTION;ORAL - 5MG/5ML;60MG/5ML Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons